Abacavir Sulfate Patent Expiration
Abacavir Sulfate is Used for the treatment of HIV/AIDS. It was first introduced by Viiv Healthcare Co
Abacavir Sulfate Patents
Given below is the list of patents protecting Abacavir Sulfate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Ziagen |
US6641843 (Pediatric) | Pharmaceutical compositions |
Aug 04, 2019
(Expired) | Viiv Hlthcare |
| Ziagen | US6641843 | Pharmaceutical compositions |
Feb 04, 2019
(Expired) | Viiv Hlthcare |
| Ziagen |
US6294540 (Pediatric) | Carbocyclic nucleoside hemisulfate and its use in treating viral infections |
Nov 14, 2018
(Expired) | Viiv Hlthcare |
| Ziagen | US6294540 | Carbocyclic nucleoside hemisulfate and its use in treating viral infections |
May 14, 2018
(Expired) | Viiv Hlthcare |
Abacavir Sulfate's Family Patents
Explore Our Curated Drug Screens
Abacavir Sulfate Generic API Manufacturers
Several generic applications have been filed for Abacavir Sulfate. The first generic version for Abacavir Sulfate was by Mylan Pharmaceuticals Inc and was approved on Jun 18, 2012. And the latest generic version is by Aurobindo Pharma Ltd and was approved on Mar 14, 2018.
Given below is the list of companies who have filed for Abacavir Sulfate generic, along with the locations of their manufacturing plants worldwide.
1. APOTEX INC
Apotex Inc has filed for 1 generic for Abacavir Sulfate. Given below are the details of the strengths of this generic introduced by Apotex Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 300MG BASE | tablet | Discontinued | ORAL | N/A | Dec 17, 2012 |
Manufacturing Plant Locations New
Apotex Inc's manufacturing plants are situated in 1 country - Canada. Given below are the details of these plant locations as well as the firm names of Apotex Inc as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| Canada |
| |||||||
2. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Abacavir Sulfate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 300MG BASE | tablet | Prescription | ORAL | AB | Dec 17, 2012 |
| EQ 20MG BASE/ML | solution | Prescription | ORAL | AA | Mar 14, 2018 |
Manufacturing Plant Locations New
Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
3. CIPLA
Cipla Ltd has filed for 1 generic for Abacavir Sulfate. Given below are the details of the strengths of this generic introduced by Cipla.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 300MG BASE | tablet | Prescription | ORAL | AB | Nov 21, 2017 |
Manufacturing Plant Locations New
Cipla's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Cipla as present at those locations.
| Country | City | Firm Name | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||
4. HETERO LABS LTD III
Hetero Labs Ltd Unit Iii has filed for 2 different strengths of generic version for Abacavir Sulfate. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd Iii.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 300MG BASE
(reference standard) | tablet | Prescription | ORAL | AB | Sep 13, 2013 |
| EQ 20MG BASE/ML | solution | Prescription | ORAL | AA | Sep 26, 2016 |
5. MYLAN PHARMS INC
Mylan Pharmaceuticals Inc has filed for 1 generic for Abacavir Sulfate. Given below are the details of the strengths of this generic introduced by Mylan Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 300MG BASE | tablet | Prescription | ORAL | AB | Jun 18, 2012 |
6. STRIDES PHARMA
Strides Pharma Global Pte Ltd has filed for 1 generic for Abacavir Sulfate. Given below are the details of the strengths of this generic introduced by Strides Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 300MG BASE | tablet | Prescription | ORAL | AB | Oct 28, 2016 |
Manufacturing Plant Locations New
Strides Pharma's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Strides Pharma as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
| India |
| |||||